BioNTech Affirms FY2026 Sales Guidance of $2.328B-$2.678B vs $2.560B Est

Benzinga Newsdesk www.benzinga.com Negative 78.0%

Neg 78% Neu 0% Pos 0%

BioNTech (NASDAQ:BNTX) affirms FY2026 sales outlook from $2.328 billion-$2.678 billion to $2.328 billion-$2.678 billion vs $2.560 billion estimate.